OpenVSafe by OpenVAERS
Search V-safe

AXW-19955-50080

2 vaccinations 5 coded responses 23 check-ins 5 free-text entries 1 call case
Sex
Male
Age at first dose
56-60
ZIP prefix
500 / IA
Registered
2021-03-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-26
    Registered in v-safe
  3. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · None
    Adult check-in
  4. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue, Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: I have M.S. so tiredness may not be related to vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Runny nose, sinus drainage. Don't believe it's related to vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-15
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-15
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  14. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site discomfort, Injection site swelling — Feeling: Good · Site: Swelling · Muscle or body aches
    Free text: Swelling at injection site lasted 3 days with discomfort.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-06
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Somnolence, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Feeling sleepy an excessive amount, even after a good night sleep. Working at home today. All I can do not to go back to bed at 4 p.m.. Made a doctor appt for tomorrow because of this excess fatigue. More than normal after weekly interferon shot. · Healthcare visit (other): In person appt for tomorrow a.m.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-06
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-05-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-27
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Visual impairment — Feeling: Fair
    Free text: Excessive fatique following my weekly Avonex (beta interferon 1a) injection. Vision is not as acute today. Seems more pronounced since vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-07-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-04-16
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-05-06

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Pfizer-BioNTech
22021-04-15Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-28

Systemic reaction (other): I have M.S. so tiredness may not be related to vaccine.

2021-03-30

Systemic reaction (other): Runny nose, sinus drainage. Don't believe it's related to vaccine.

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): Swelling at injection site lasted 3 days with discomfort.

Release 8 — day 21, dose 2

2021-05-06

Symptoms: Feeling sleepy an excessive amount, even after a good night sleep. Working at home today. All I can do not to go back to bed at 4 p.m.. Made a doctor appt for tomorrow because of this excess fatigue. More than normal after weekly interferon shot.
Healthcare visit (other): In person appt for tomorrow a.m.

Release 8 — day 42, dose 2

2021-05-27

Symptoms: Excessive fatique following my weekly Avonex (beta interferon 1a) injection. Vision is not as acute today. Seems more pronounced since vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDSomnolence ✓ ✓ ✓
SDVisual impairment ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROInjection site discomfort ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release